Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform 2022-12-05 20:30
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022 2022-12-04 17:00
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential 2022-12-03 09:58
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus 2022-12-03 05:05
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022 2022-12-02 16:20
Waterdrop Inc. to Report Third Quarter 2022 Financial Results on December 6, 2022 2022-12-02 11:43
Jacobio's Preclinical Results of KRAS G12C Inhibitor in Combination with SHP2 Inhibitor Will be Presented at the ESMO Asia Congress 2022 2022-12-02 08:30
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met 2022-12-01 19:30
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results 2022-12-01 15:33
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO 2022-12-01 09:30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio 2022-12-01 08:00
TIANGEN to Roll out a Stunning Automated Solution at Cell Bio 2022 2022-11-30 21:20
Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne 2022-11-30 20:39
Navigating a perfect storm - driving access to healthcare in emerging markets 2022-11-30 15:00
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan 2022-11-30 08:00
United Imaging Selected to Academy of Radiology & Biomedical Imaging Research's Council of Distinguished Investigators' Class of 2022 2022-11-29 22:00
1 91 92 93 94 95 766